zip >>> 10016
sector >>> Healthcare
fullTimeEmployees >>> 30000
longBusinessSummary >>> Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. The company's products include Opdivo for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, it offers Reyataz, a protease inhibitor to treat human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, Ubiquigent Limited, Checkmate Pharmaceuticals, and Sensyne Health plc; clinical collaboration with NeoImmuneTech, Inc.; partnership with Astrazeneca Plc; a discovery collaboration with Insitro, Inc.; and collaboration with SchrÃ¶dinger, Inc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
city >>> New York
phone >>> 212 546 4000
state >>> NY
country >>> United States
companyOfficers >>> []
website >>> http://www.bms.com
maxAge >>> 1
address1 >>> 430 East 29th Street
industry >>> Drug Manufacturers—General
address2 >>> 14th Floor
previousClose >>> 66.74
regularMarketOpen >>> 66.57
twoHundredDayAverage >>> 61.114235
trailingAnnualDividendYield >>> 0.026970332
payoutRatio >>> None
volume24Hr >>> None
regularMarketDayHigh >>> 66.82
navPrice >>> None
averageDailyVolume10Day >>> 13153733
totalAssets >>> None
regularMarketPreviousClose >>> 66.74
fiftyDayAverage >>> 62.40515
trailingAnnualDividendRate >>> 1.8
open >>> 66.57
toCurrency >>> None
averageVolume10days >>> 13153733
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> 1.96
exDividendDate >>> 1609372800
beta >>> 0.65126
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 66
priceHint >>> 2
currency >>> USD
regularMarketVolume >>> 9374623
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 149708423168
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 10552880
priceToSalesTrailing12Months >>> 3.8001883
dayLow >>> 66
ask >>> 66.39
ytdReturn >>> None
askSize >>> 800
volume >>> 9374623
fiftyTwoWeekHigh >>> 68.34
forwardPE >>> 8.892617
fromCurrency >>> None
fiveYearAvgDividendYield >>> 2.81
fiftyTwoWeekLow >>> 45.76
bid >>> 66.31
tradeable >>> False
dividendYield >>> 0.0295
bidSize >>> 2200
dayHigh >>> 66.82
exchange >>> NYQ
shortName >>> Bristol-Myers Squibb Company
longName >>> Bristol-Myers Squibb Company
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EST
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -18000000
quoteType >>> EQUITY
symbol >>> BMY
messageBoardId >>> finmb_25798
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 4.453
beta3Year >>> None
profitMargins >>> -0.00112
enterpriseToEbitda >>> 10.43
52WeekChange >>> -0.010232866
morningStarRiskRating >>> None
forwardEps >>> 7.45
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 2259749888
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 22.196
sharesShort >>> 15015112
sharesPercentSharesOut >>> 0.0066000004
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.75788003
netIncomeToCommon >>> -44000000
trailingEps >>> -0.022
lastDividendValue >>> 0.49
SandP52WeekChange >>> 0.1436472
priceToBook >>> 2.9847722
heldPercentInsiders >>> 0.00083
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1601424000
shortRatio >>> 1.51
sharesShortPreviousMonthDate >>> 1606694400
floatShares >>> 2226804341
enterpriseValue >>> 175414820864
threeYearAverageReturn >>> None
lastSplitDate >>> 997142400
lastSplitFactor >>> 1000000:951777
legalType >>> None
lastDividendDate >>> 1609372800
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> 0.384
dateShortInterest >>> 1609372800
pegRatio >>> 0.49
lastCapGain >>> None
shortPercentOfFloat >>> 0.0066000004
sharesShortPriorMonth >>> 15298446
impliedSharesOutstanding >>> None
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 66.57
logo_url >>> https://logo.clearbit.com/bms.com
